The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders by Langerak, A.W. (Anton) et al.
The role of molecular analysis of immunoglobulin
and T cell receptor gene rearrangements in the
diagnosis of lymphoproliferative disorders
A W Langerak, J H J M van Krieken, I L M Wolvers-Tettero, E Kerkhof, A H Mulder,
L W M A Vrints, J W Coebergh, E Schuuring, Ph M Kluin, J J M van Dongen
Abstract
Aims—To investigate whether the analysis
of immunoglobulin (Ig)/T cell receptor
(TCR) rearrangements is useful in the
diagnosis of lymphoproliferative disor-
ders.
Methods—In a series of 107 consecutive
cases with initial suspicion of non-
Hodgkin’s lymphoma (NHL), Southern
blot (SB) analysis of Ig/TCR rearrange-
ments was performed.
Results—In 98 of 100 histopathologically
conclusive cases, Ig/TCR gene results were
concordant. In one presumed diVuse large
B cell lymphoma (DLCL) and one follicu-
lar lymphoma (FL) case no clonality could
be detected by SB analysis, or by polymer-
ase chain reaction (PCR) at second stage.
In the DLCL, sampling error might have
occurred; the FL was revised after an ini-
tial diagnosis of reactivity. In many of the
histopathologically inconclusive cases Ig/
TCR gene SB analysis was helpful, giving
support for the histopathological suspi-
cion. However, because of a lack of (clini-
cal) follow up data this could not be
confirmed in a few cases.
Conclusions—Experienced haemato-
pathologists or a pathologist panel can
diagnose malignant versus reactive le-
sions in most cases without the need for
Ig/TCR gene analysis and can select the
5–10% of cases that might benefit from
molecular clonality studies.
(J Clin Pathol 2001;54:565–567)
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Combined histomorphology and immunohis-
tochemistry is often suYcient for a reliable
diagnosis of lymphoproliferative lesions. How-
ever, the crucial distinction between polyclo-
nality and monoclonality is sometimes diYcult
to make. In the case of B cell proliferations,
immunoglobulin (Ig) (ê or ë) light chain
restriction analysis is widely applied for clonal-
ity assessment, but this method can be techni-
cally diYcult in tissue sections. Furthermore,
in Ig negative (Ig−) B cell lesions and T cell
proliferations no such strategy is available. For
this reason, molecular studies using Southern
blot (SB) and/or polymerase chain reaction
(PCR) analysis of Ig and T cell receptor (TCR)
genes are currently used. Based on the idea that
malignancies are clonal proliferations derived
from a single transformed cell, the presence or
absence of clonal Ig/TCR rearrangements is
used to discriminate between neoplastic and
reactive proliferations, respectively.
Although molecular analysis of Ig/TCR
genes has proved very helpful in selected cases,
limited information is available about its appli-
cability in daily practice. Therefore, we con-
ducted a prospective study on 107 consecutive
cases selected on the basis of a histopathologi-
cal suspicion of non-Hodgkin’s lymphoma
(NHL) or reactive lymphoproliferative disor-
der. Samples were analysed by standard immu-
nohistochemistry and included in the study if
enough frozen material was available for SB
analysis. Despite the obvious advantages of
PCR based methods, SB is still regarded as the
gold standard because of its very low rate of
false negativity and false positivity. Therefore,
SB was considered the most appropriate
method to evaluate the role of molecular tech-
niques in clonality studies for lymphoma diag-
nosis.
Material and methods
PATIENT MATERIAL
A total of 107 consecutive diagnostic samples
(derived from four pathology laboratories—
Leiden/The Hague, Dordrecht, and Eind-
hoven) with an initial histomorphological
suspicion of NHL were analysed by standard
immunohistochemistry (including Ig light
chain restriction). Cases were included based
on the availability of frozen tissue for SB analy-
sis. NHL samples were classified according to
the REAL classification.1 Histological slides
from all cases were reviewed blindly by a panel
of four haematopathologists (JHJMvK, AHM,
LWMAV, and PMK). Unexpected findings
and/or discrepancies between histo-
morphology/immunohistochemistry and SB
analysis were analysed in a second panel meet-
ing, where a final diagnosis was reached.
SOUTHERN BLOT ANALYSIS
SB analysis of Ig/TCR genes2 was performed in
two molecular diagnostic laboratories (AWL/
JJMvD, Rotterdam and ES/PMK, Leiden) with
the following probes: IGHJ6, IGKJ5, IGKC,
IGKDE, IGLC3, TCRBJ1, TCRBJ2,
TCRBC, TCRGJ13, TCRGJ21, TCRDJ1,
and TCRDC4 (DAKO Corporation, Carpinte-
ria, California, USA) in combination with the
optimal restriction enzyme digests.3–6 Rear-
rangements were only regarded as clonal when
detected in two distinct digests.
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Results and discussion
Based on haematoxylin and eosin stained
sections and immunohistochemistry, a clear
histopathological diagnosis was reached in 100
of the 107 samples analysed (table 1). In 98 of
these, the results of the blindly performed par-
allel SB analyses completely matched the
histopathological diagnosis, supporting the
assumption that for these cases molecular
analysis would have been unnecessary in a rou-
tine diagnostic setting. One case was originally
diagnosed as a reactive lymphoproliferation,
but was revised by the pathologists panel as Ig−
follicular lymphoma (FL), and indeed con-
tained clonal Ig rearrangements. Furthermore,
two anaplastic large cell lymphomas (ALCLs)
did not contain clonal TCR or Ig rearrange-
ments (null-type), whereas in the third one of
these lymphomas clonal TCRB (TCR â chain)
gene rearrangements were observed. Remark-
ably, in four mantle cell lymphomas (MCLs)
and three lymphocytic lymphomas (LLs),
crosslineage TCRB gene rearrangements were
observed next to Ig rearrangements. This phe-
nomenon has been described previously and
confirms the notion that TCR rearrangements
are not proof of the T cell lineage of a
tumour.2 7 Clonal IGH (Ig heavy chain) gene
rearrangements were also observed in both
acute myeloid lymphoma (AML) cases, one of
which also showed TCR rearrangements. This
is a remarkable observation, given the low
(approximately 15%) frequency of Ig/TCR
recombinations in random AML series.2
Clonal rearrangements were not detected in
the reactive lymphoproliferations.
One presumed diVuse large B cell lymphoma
(DLCL) and one presumed FL out of the 100
cases showed discordant molecular results
(table 1). They are presented in more detail,
together with seven cases with inconclusive
histopathological diagnosis, in table 2. PCR
analysis on paraYn wax and frozen tissue of the
discordant cases did not show clonal IGH
rearrangements either,8 although false negative
PCR results cannot be excluded. The DLCL
case probably represented a sampling error,
because the diagnosis was also clear from an
earlier biopsy. The presumed FL was initially
thought to be reactive, but unfortunately noth-
ing is known from later biopsies.
When the seven inconclusive samples were
studied by SB, the molecular data appeared to
direct the final diagnosis in virtually all cases.
The two suspected B cell NHL (B-NHL) cases
and the suspected acute lymphoblastic leukae-
mia (ALL) case all showed clonal Ig rearrange-
ments, although PCR failed to detect clonality,
possibly as a result of incomplete rearrange-
ments or somatic hypermutations. Although
clonality detection per se cannot be considered
to be proof of malignancy, in the context of a
histopathologically suspect lesion it was con-
sidered to support the malignant character of
these samples. In one suspected B-NHL, this
was confirmed by information from a later
biopsy. In one of the two cases with features of
both B-NHL and Hodgkin’s disease (HD),
clonal Ig rearrangements were observed by SB
analysis. The results implied that one con-
cerned B-NHL (94-105) and the other HD
(95-056), although no definite distinction
Table 1 Southern blot (SB) analysis of Ig/TCR genes in cases with a clear
histopathological diagnosis (n = 100)
Histopathological diagnosis
No. of
samples SB analysis of Ig/TCR genes
Haematopoietic
DiVuse large B cell lymphoma (DLCL) 18 Clonal (Ig) 17
Non-clonal 1*
Follicular lymphoma (FL) 16 Clonal (Ig) 15
Non-clonal 1*
Lymphocytic lymphoma (LL) 17 Clonal (Ig) 17
Mantle cell lymphoma (MCL) 7 Clonal (Ig) 7
MALT lymphoma 1 Clonal (Ig) 1
Burkitt’s lymphoma (BL) 1 Clonal (Ig) 1
Plasmacytoma (PC) 1 Clonal (Ig) 1
T cell lymphoma (T-NHL) 1 Clonal (TCR) 1
Anaplastic large cell lymphoma (ALCL) 3 Clonal (TCR) 1
Non-clonal 2
Hodgkin’s disease (HD) 4 Non-clonal 4
Acute myeloid leukaemia (AML) 2 Clonal (Ig) 1
Clonal (Ig+TCR) 1
Non-haematopoietic
Kaposi’s sarcoma 1 Non-clonal 1
Seminoma 1 Non-clonal 1
Reactive lymphoproliferations 27 Non-clonal 27
*Cases are discussed in more detail in table 2.
Ig, immunoglobulin; TCR, T cell receptor.
Table 2 Southern blot analysis of Ig/TCR genes in patients with discordant molecular results (n = 2) or inconclusive histopathological diagnosis (n = 7)
Case Category
Combined histomorphology and
immunohistochemistry
SB analysis of Ig/TCR
genes
PCR analysis of IGH
genes (FR3/FR2/FR1) Follow up analysis and clinical data
767 Discordant DLCL Non-clonal Polyclonal Diagnosis of B-NHL also based on earlier
biopsy; treated for B-NHL
95-040 Discordant FL (revised; initially reactive) Non-clonal Polyclonal Unknown
759 Inconclusive Suspected B-NHL (LL) Clonal Polyclonal Unknown
(IGH/IGK)
766 Inconclusive Suspected acute lymphoblastic leukaemia Clonal Polyclonal Not treated, despite presence of TdT+ cells
in lymph node(IGH/IGK/IGL)
818 Inconclusive Suspected B-NHL Clonal Polyclonal Diagnosis of DLCL on next biopsy; relapse
of DLCL in neck 4 years later(IGH/TCRB)
94-105 Inconclusive DiVerential diagnosis, B-NHL/HD Clonal Clonal Remission after treatment for T rich B-NHL;
(IGH/IGK) (FR2/FR1) 2 years later presentation of lymphocyte rich
nodular HD; B-NHL perceived as
transformed phase of underlying HD
95-056 Inconclusive DiVerential diagnosis, HD/B-NHL Non-clonal Polyclonal Treated for lymphocyte rich nodular HD;
follow up 4 years later: no localisation of HD
in lymph node
95-054 Inconclusive Reactive, but suspect Non-clonal Polyclonal Treated for nodular sclerotic HD; follow up
1 year later: reactive lymph node
95-036 Inconclusive Suspected T-NHL Non-clonal ND Sepsis leading to death; AILD T-NHL at
necropsy
AILD, angioimmunoblastic lymphoproliferative disease; B-NHL, B cell non-Hodgkin’s lymphoma; DLCL, diVuse large B cell lymphoma; FL, follicular lymphoma;
FR, framework region; HD, Hodgkin’s disease; IGH, immunoglobulin heavy chain; LL, lymphocytic leukaemia; TCR, T cell receptor; TdT, terminal deoxy
nucleotidyl transferase; T-NHL, T cell non-Hodgkin’s lymphoma.
566 Short report
www.jclinpath.com
group.bmj.com on November 17, 2015 - Published by http://jcp.bmj.com/Downloaded from 
could be made, given the description of IGH
clonality in HD9 10 and the variable number of
tumour cells in this disease. Follow up analysis
revealed that 94-105 was later diagnosed as T
rich B-NHL (perceived as transformed phase
of underlying HD), whereas in 95-056, no fea-
tures of HD were found in later biopsies.
Finally, one atypical, presumably reactive, but
suspect lesion as well as a case with a strong
suspicion for T cell NHL (T-NHL) did not
contain clonal rearrangements. We regard this
as support for the non-malignant character of
these lesions, although a small tumour load
(< 5%) cannot be fully excluded. Follow up
analysis revealed a clear reactive lymph node
lesion in the former case, but in the second case
an angioimmunoblastic lymphoproliferative
disease T-NHL was apparent at necropsy.
Although the results of our study are clear,
the role of molecular clonality analysis is still
not fully defined. First, although reflecting
daily practice in two academic and two
non-academic centres, the initial diagnoses
were made by a panel of experienced haemato-
pathologists with the availability of frozen
tissue for extensive immunohistochemical
analysis. Second, in this prospective study,
T-NHL and other rare lymphomas were
present in only small numbers. Nevertheless,
the study does show that SB analysis is of help
in diagnosing histopathologically suspect lym-
phoproliferative lesions, although the true
eVectiveness of molecular techniques can only
be properly assessed with the availability of
long term clinical follow up data. Because a
panel of pathologists should be able to select
the relatively few suspect cases, this further
indicates that molecular clonality assessment
can only become cost eVective when a central
facility is organised with enough experience in
haematopathology and molecular immunol-
ogy. Furthermore, quality control studies and
interlaboratory standardisation are needed for
the routine application of molecular clonality
techniques.
The major problem with SB analysis of
Ig/TCR gene rearrangements is the need for a
suYcient amount of frozen material and the
relatively long time taken to obtain results.
Therefore, several more rapid and cheaper
PCR based techniques are used at present.
Although these techniques yield a relatively
high number of false negative results,8 they are
very useful as an initial screening tool.
However, comparative multicentre studies are
essential to establish the real value of PCR
techniques. This is the aim of the current
BIOMED-2 Concerted Action (PL96–3936)
on “Development and standardisation of PCR
based clonality studies in lymphoproliferative
disorders”.
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